- Home
- GDEV vs RNAC Comparison
GDEV vs RNAC Comparison
Compare GDEV & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDEV
- RNAC
- Stock Information
- Founded
- GDEV 2009
- RNAC 2007
- Country
- GDEV Cyprus
- RNAC United States
- Employees
- GDEV N/A
- RNAC N/A
- Industry
- GDEV EDP Services
- RNAC Biotechnology: Pharmaceutical Preparations
- Sector
- GDEV Technology
- RNAC Health Care
- Exchange
- GDEV Nasdaq
- RNAC Nasdaq
- Market Cap
- GDEV 520.6M
- RNAC 472.7M
- IPO Year
- GDEV N/A
- RNAC 2016
- Fundamental
- Price
- GDEV $26.00
- RNAC $17.33
- Analyst Decision
- GDEV Buy
- RNAC Strong Buy
- Analyst Count
- GDEV 2
- RNAC 7
- Target Price
- GDEV $70.00
- RNAC $40.80
- AVG Volume (30 Days)
- GDEV 6.9K
- RNAC 107.5K
- Earning Date
- GDEV 11-14-2024
- RNAC 11-07-2024
- Dividend Yield
- GDEV N/A
- RNAC N/A
- EPS Growth
- GDEV N/A
- RNAC N/A
- EPS
- GDEV 2.48
- RNAC N/A
- Revenue
- GDEV $443,165,000.00
- RNAC $47,938,000.00
- Revenue This Year
- GDEV N/A
- RNAC $69.22
- Revenue Next Year
- GDEV $6.12
- RNAC N/A
- P/E Ratio
- GDEV $10.50
- RNAC N/A
- Revenue Growth
- GDEV N/A
- RNAC N/A
- 52 Week Low
- GDEV $19.00
- RNAC $11.67
- 52 Week High
- GDEV $42.76
- RNAC $42.60
- Technical
- Relative Strength Index (RSI)
- GDEV 39.77
- RNAC 39.04
- Support Level
- GDEV $24.30
- RNAC $15.50
- Resistance Level
- GDEV $32.60
- RNAC $22.20
- Average True Range (ATR)
- GDEV 2.94
- RNAC 1.65
- MACD
- GDEV -1.03
- RNAC -0.56
- Stochastic Oscillator
- GDEV 9.21
- RNAC 24.43
About GDEV GDEV Inc.
GDEV Inc is a gaming and entertainment holding company that oversees a portfolio of studios focused on developing and publishing live-service games across a range of platforms and genres. Its portfolio includes studios specializing in mobile, browser, and PC games, as well as captivating IPs spanning various genres.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. It leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.